N-acetyltransferase 2
From Wikipedia, the free encyclopedia
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|||||||||||
PDB rendering based on 2pfr. | |||||||||||
Available structures: 2pfr | |||||||||||
Identifiers | |||||||||||
Symbol(s) | NAT2; AAC2 | ||||||||||
External IDs | OMIM: 243400 MGI: 97279 HomoloGene: 32047 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 10 | 17960 | |||||||||
Ensembl | ENSG00000156006 | ENSMUSG00000025588 | |||||||||
Uniprot | P11245 | Q546L3 | |||||||||
Refseq | NM_000015 (mRNA) NP_000006 (protein) |
NM_008673 (mRNA) NP_032699 (protein) |
|||||||||
Location | Chr 8: 18.29 - 18.3 Mb | Chr 8: 70.42 - 70.42 Mb | |||||||||
Pubmed search | [1] | [2] |
N-acetyltransferase 2 (arylamine N-acetyltransferase), also known as NAT2, is a human gene.
This gene encodes N-acetyltransferase 2 (arylamine N-acetyltransferase 2). This enzyme functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are reponsible for the N-acetylation polymorphism in which human populations segregate into rapid,intermediate, and slow acetylator phenotypes. Polymorphisms in NAT2 are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near NAT2.[1]
[edit] References
[edit] Further reading
- Vatsis KP, Weber WW, Bell DA, et al. (1995). "Nomenclature for N-acetyltransferases.". Pharmacogenetics 5 (1): 1–17. PMID 7773298.
- Windmill KF, McKinnon RA, Zhu X, et al. (1997). "The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.". Mutat. Res. 376 (1-2): 153–60. PMID 9202751.
- Lan Q, Rothman N, Chow WH, et al. (2003). "No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.". Cancer Epidemiol. Biomarkers Prev. 12 (4): 384–6. PMID 12692115.
- Ochs-Balcom HM, Wiesner G, Elston RC (2007). "A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.". Am. J. Epidemiol. 166 (3): 246–54. doi: . PMID 17535831.
- Sanderson S, Salanti G, Higgins J (2007). "Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.". Am. J. Epidemiol. 166 (7): 741–51. doi: . PMID 17675654.